Prévisions du marché des diagnostics moléculaires au point de service en Amérique du Sud et centrale jusqu’en 2028 – Impact du COVID-19 et analyse régionale par produits et services (tests et kits, instruments, services et logiciels), technologie (PCR, technologie d’amplification des acides nucléiques isothermes ( INAAT) et autres technologies), application (maladies infectieuses, oncologie, hématologie, tests prénatals, endocrinologie et autres applications), utilisateur final (hôpitaux et cliniques, laboratoires de diagnostic, instituts de recherche et universitaires et autres)
Introduction au marché
Les diagnostics moléculaires au point d\'intervention comprennent des appareils portables et des tests et ; kits utilisés pour détecter et diagnostiquer des maladies dans des échantillons humains, tels que des prélèvements de gorge, du sang, du sérum et des selles. Les diagnostics moléculaires passent des laboratoires centralisés aux tests moléculaires décentralisés sur les lieux d\'intervention. En raison de sa simplicité, de sa commodité, de son délai d\'exécution rapide et de son potentiel d\'amélioration des résultats pour les patients, le POCT gagne rapidement du terrain.
De plus, la demande croissante de méthodes de détection virale spécifiques qui consomment on s\'attend à ce que moins de temps pour contrôler les infections en temps opportun soutienne la croissance du marché au cours de la période de prévision.
Le Brésil a signalé le plus grand nombre de cas de COVID-19 en Amérique du Sud et en Amérique centrale, suivi par l\'Argentine, le Pérou, le Chili et l\'Équateur, entre autres. Les gouvernements des pays de cette région ont pris plusieurs mesures pour protéger leurs citoyens et contenir la propagation de la maladie. La propagation continue du COVID-19 stimule la croissance du marché du diagnostic au point d’intervention. En outre, l\'augmentation de la demande de solutions de diagnostic modernisées pour le COVID-19 devrait également avoir un impact positif sur la croissance du marché du diagnostic moléculaire au point d\'intervention en Amérique du Sud et en Amérique centrale.
< span>
Aperçu et dynamique du marché
Le Sud et le Sud Le marché des diagnostics moléculaires au point de service en Amérique centrale devrait atteindre 282,2 millions de dollars américains d’ici 2028, contre 123,4 millions de dollars américains en 2021. Le marché devrait croître à un TCAC de 12,5 % de 2021 à 2028. L’essor des gadgets électroniques grand public connectés a transformé des secteurs entiers de l’économie, y compris la santé. Les patients et les consommateurs ajustent leurs interactions avec les produits médicaux et les produits POC. services en raison de la pénétration des appareils mobiles. De plus, avec l’essor des gadgets connectés, les consommateurs transforment la façon dont ils gèrent et prennent le contrôle de leur santé. Par conséquent, les fabricants développent des dispositifs de diagnostic moléculaire POC faciles à utiliser, pratiques et abordables pour les environnements hors laboratoire afin de répondre à la demande croissante des consommateurs. Les dispositifs de diagnostic et de surveillance moléculaires POC devraient devenir monnaie courante à l\'avenir dans les environnements résidentiels des économies à revenu faible et intermédiaire en raison de l\'émergence rapide du paysage technologique et de la pénétration croissante des smartphones et des appareils connectés.
Segments clés du marché
En termes de produits et de produits. services, le segment des tests et des kits représentait la plus grande part du marché Sud & Marché du diagnostic moléculaire au point de service en Amérique centrale en 2020. En termes de technologie, le segment PCR représentait la plus grande part du marché du Sud et du Sud. Marché du diagnostic moléculaire au point de service en Amérique centrale en 2020. En termes d’application, le segment des maladies infectieuses représentait la plus grande part du marché du Sud et du Sud. Marché du diagnostic moléculaire au point de service en Amérique centrale en 2020. En termes d’utilisateurs finaux, le segment des laboratoires de diagnostic représentait la plus grande part du marché du Sud et du Sud. Marché du diagnostic moléculaire au point de service en Amérique centrale en 2020.
Principales sources et sociétés répertoriées
Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché des diagnostics moléculaires au point de service dans les pays du Sud et du Sud. L\'Amérique centrale comprend, entre autres, des sites Web d\'entreprises, des rapports annuels, des rapports financiers, des documents gouvernementaux nationaux et des bases de données statistiques. Les principales sociétés répertoriées dans le rapport sont bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, Meridian BioScience, Inc., Biocartis, Quidel Corporation et Bio-Rad Laboratories, Inc. .
Rapport sur les raisons d\'acheter
- Pour comprendre le Sud et le Sud Paysage du marché du diagnostic moléculaire au point de service en Amérique centrale et identifier les segments de marché susceptibles de garantir un fort retour.
- Pour comprendre le paysage du marché en constante évolution et rester en tête face à la concurrence
- Pour planifier efficacement les fusions, acquisitions et accords de partenariat dans les pays du Sud et du Sud. Marché du diagnostic moléculaire au point de service en Amérique centrale en identifiant les segments avec les ventes probables les plus prometteuses
- Prendre des décisions commerciales éclairées à partir d’une analyse perspicace et complète des performances du marché de divers segments
- Pour obtenir les prévisions de revenus du marché du Sud et du Sud. Marché du diagnostic moléculaire au point de service en Amérique centrale basé sur divers segments pour la période 2021-2028
SUD & SEGMENTATION DU MARCHÉ DU DIAGNOSTIC MOLÉCULAIRE AU POINT DE SOINS EN AMÉRIQUE CENTRALE
< span>Par Produit etamp; Services
- Tests et kits
- Instruments
- Services et logiciels
Par technologie
- PCR
- Technologie d\'amplification isotherme des acides nucléiques (INAAT)
- Autres technologies
Par Application
- Maladies infectieuses
- Oncologie
- Hématologie
- Tests prénatals
- Endocrinologie
- Autres applications
Par Utilisateur final
- Hôpitaux et cliniques
- Laboratoires de diagnostic
- Instituts de recherche et universitaires
- Autres
Par pays
- Sud etamp; Amérique centrale
- Brésil
- Argentine
- Reste du Sud et du Sud Amérique centrale
Entreprises mentionnées
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 South & Central America Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 South & Central America Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 South & Central America Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 South & Central America Point-of-Care Molecular Diagnostics Market– By Geography
2. South & Central America Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– South & Central America Analysis
6.1 South & Central America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 South and Central America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.1.4 South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.1.5 South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.1.6 South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.1.7 South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.1.7.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.1.3 Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.1.4 Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.1.5 Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.2 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.2.3 Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.2.4 Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.2.5 Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.3.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.3.4 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.3.5 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 2. South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 3. South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. South & Central America Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in South & Central America Point-of-Care Molecular Diagnostics Market
Figure 4. Brazil to Show Significant Growth During Forecast Period
Figure 5. South & Central America Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. South & Central America PEST Analysis
Figure 7. South & Central America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 29. South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 31. Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South & Central America
Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Point-of-Care molecular diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.